Recombinant Pelobacter propionicus Methionyl-tRNA formyltransferase (fmt)

What is Methionyl-tRNA formyltransferase (Fmt) and why is it important in bacterial translation?

Methionyl-tRNA formyltransferase (Fmt) is an essential enzyme that catalyzes the formylation of initiator methionyl-tRNA (Met-tRNA^fMet) to formylmethionyl-tRNA (fMet-tRNA^fMet). This formylation reaction is crucial for efficient initiation of protein synthesis in bacteria and eukaryotic organelles including mitochondria and chloroplasts. The formyl group attached to methionine in the initiator tRNA serves as a positive determinant for the initiation factor IF2 and as a negative determinant for the elongation factor EF-Tu, thus ensuring that the initiator tRNA participates exclusively in translation initiation rather than elongation . Recent research has also demonstrated that Fmt-mediated formylation is important for maintaining translation initiation fidelity .

How does Fmt fit into the one-carbon metabolic pathway?

Fmt functions as a critical node connecting the folate pathway with protein synthesis. In the canonical pathway, the folate metabolite 10-formyltetrahydrofolate (10-CHO-THF) serves as the formyl group donor for Fmt. This 10-CHO-THF is generated by the bifunctional enzyme folate dehydrogenase-cyclohydrolase (FolD), which converts 5,10-methylene tetrahydrofolate (5,10-CH2-THF) to 5,10-methenyltetrahydrofolate (5,10-CH+-THF) through its dehydrogenase activity, and subsequently converts this intermediate to 10-CHO-THF via its cyclohydrolase activity . The formylation of Met-tRNA^fMet by Fmt represents one of several metabolic fates for 10-CHO-THF, which is also utilized in purine nucleotide biosynthesis by enzymes like glycinamide ribonucleotide transformylase (PurN) and aminoimidazole carboxamide ribonucleotide transformylase (AICAR transformylase, part of PurH) .

What is unique about Pelobacter propionicus Fmt compared to other bacterial Fmt enzymes?

While the search results do not provide specific information on unique features of P. propionicus Fmt, we can infer from comparative studies of formyltransferases that these enzymes share considerable structural and functional conservation across bacterial species. Research on various Fmt enzymes has demonstrated that they typically contain conserved motifs involved in substrate binding and catalysis. The P. propionicus Fmt would be expected to share core enzymatic mechanisms with better-characterized Fmt enzymes from model organisms like E. coli, while potentially exhibiting species-specific adaptations related to the anaerobic lifestyle and metabolic requirements of P. propionicus.

What are the known substrates for bacterial Fmt enzymes?

Recent research has revealed important findings regarding Fmt substrate specificity:

The most significant recent discovery is that 10-formyldihydrofolate (10-CHO-DHF) can serve as an alternative formyl group donor for Fmt. This finding expands our understanding of Fmt's substrate utilization and its role in one-carbon metabolism under various physiological conditions .

How can researchers design experiments to investigate Fmt substrate specificity?

To investigate Fmt substrate specificity, researchers can employ the following methodological approaches:

• In vitro formylation assays: Purify recombinant Fmt and prepare Met-tRNA^fMet by charging deacylated tRNA^fMet with methionine using purified methionyl-tRNA synthetase (MetRS). Then test various potential formyl donors, including 10-CHO-THF and 10-CHO-DHF, in formylation reactions. The formylation status can be analyzed by acid urea PAGE followed by Northern blotting using probes specific to tRNA^fMet .

• LC-MS/MS analysis: Analyze reaction by-products (such as DHF or THF) by liquid chromatography-tandem mass spectrometry to confirm the transfer of the formyl group from the donor molecule .

• Antifolate sensitivity assays: Compare the sensitivity of wild-type, Fmt-overexpressing, and Fmt-deficient strains to antifolates like trimethoprim. Increased sensitivity in Fmt-overexpressing strains may indicate utilization of alternative substrates under folate-restricted conditions .

• Folate metabolite profiling: Quantify various folate species (reduced and oxidized) under different growth conditions and in response to antifolate treatments to correlate changes in folate pools with Fmt activity and protein synthesis initiation .

What are the recommended methods for expressing and purifying recombinant P. propionicus Fmt?

Based on established protocols for bacterial Fmt enzymes, the following methodological approach is recommended:

• Vector construction: Clone the fmt gene from P. propionicus genomic DNA into an expression vector with an appropriate tag (e.g., 6×His) for purification. Vector systems like pET are commonly used for recombinant protein expression in E. coli .

• Expression host: Transform the expression construct into an E. coli strain optimized for protein expression, such as BL21(DE3), which was successfully used for human mt-MTF expression .

• Induction conditions: Optimize expression by testing different induction conditions (IPTG concentration, temperature, duration). Based on protocols for E. coli Fmt and human mt-MTF, induction at lower temperatures (16-25°C) for extended periods (overnight) may improve solubility .

• Purification strategy: Employ metal affinity chromatography for initial purification of His-tagged recombinant Fmt, followed by size exclusion chromatography to achieve high purity. Maintain reducing conditions throughout purification to preserve enzyme activity .

• Activity preservation: Include glycerol (10-20%) in storage buffers and store purified enzyme at -80°C in small aliquots to preserve activity for extended periods .

How can the enzymatic activity of recombinant P. propionicus Fmt be measured?

The enzymatic activity of recombinant Fmt can be measured using several complementary approaches:

• In vitro formylation assay: This is the gold standard method for determining Fmt activity. The assay requires:

  • Purified initiator tRNA^fMet (can be isolated from a Δfmt strain overexpressing tRNA^fMet)

  • Purified methionyl-tRNA synthetase (MetRS) to charge the tRNA with methionine

  • Purified Fmt enzyme

  • Formyl donor (10-CHO-THF or 10-CHO-DHF)

  The reaction involves first charging the tRNA^fMet with methionine, then adding Fmt and the formyl donor. The formylation status can be analyzed by acid urea PAGE followed by Northern blotting using probes specific to tRNA^fMet .

• Steady-state kinetics: Determine Km and Vmax values for both Met-tRNA^fMet and formyl donors (10-CHO-THF and 10-CHO-DHF) by varying substrate concentrations and measuring initial velocities. This approach has been successfully used to characterize human mt-MTF variants and their E. coli MTF counterparts .

• Complementation assays: Test the ability of recombinant P. propionicus Fmt to complement E. coli Fmt deficiency in vivo, which provides a functional readout of enzyme activity in a cellular context .

What are the key analytical methods for studying Fmt-catalyzed reactions?

Several analytical methods have been established for studying Fmt-catalyzed reactions:

• Northern blotting analysis: This technique allows for the detection and quantification of different forms of tRNA^fMet (deacylated, methionylated, and formylmethionylated) separated by acid urea PAGE. It requires preparation of total tRNAs under cold and acidic conditions to preserve the ester bond linking amino acids to tRNA .

• LC-MS/MS analysis: This approach enables the detection and quantification of folate metabolites involved in the Fmt reaction, including the formyl donors (10-CHO-THF, 10-CHO-DHF) and products (THF, DHF) .

• Enzymatic coupled assays: These assays can be designed to measure Fmt activity by coupling it to the production or consumption of a detectable product. For example, the formation of DHF from 10-CHO-DHF could be coupled to NADPH oxidation through DHFR activity, allowing for continuous spectrophotometric monitoring .

• Radioisotope-based assays: These assays can provide high sensitivity for measuring Fmt activity using radiolabeled substrates (e.g., [14C]-methionine or [3H]-formyl donors) .

How do mutations in Fmt affect enzyme activity and what can we learn from human mt-MTF mutations?

Studies of human mitochondrial MTF (mt-MTF) mutations associated with Leigh syndrome provide valuable insights into structure-function relationships in formyltransferases. Two pathogenic mutations, S125L and S209L, were characterized in detail:

These mutations affect conserved residues, highlighting the importance of strategic positioning of small aliphatic amino acids for normal MTF function. The S125L mutation has a dramatically greater impact on enzyme efficiency than S209L, suggesting a critical role for this residue in catalysis or substrate binding .

The functional characterization of these mutations demonstrates that:

• Even residues not directly involved in catalysis can have profound effects on enzyme activity when mutated

• Conservative substitutions (serine to leucine) can significantly impair function

• Residual enzyme activity (from the S209L variant) appears sufficient to sustain a low level of mitochondrial translation in patients

What approaches can be used to generate and characterize P. propionicus Fmt mutants?

To generate and characterize P. propionicus Fmt mutants, researchers can employ the following methodological approaches:

• Site-directed mutagenesis: Target conserved residues identified through sequence alignment with well-characterized Fmt enzymes (e.g., E. coli Fmt, human mt-MTF). PCR-based mutagenesis techniques can be used to create specific mutations in the cloned fmt gene .

• Alanine-scanning mutagenesis: Systematically replace suspected catalytic or substrate-binding residues with alanine to assess their contribution to enzyme function.

• Comparative mutational analysis: Create mutations in P. propionicus Fmt corresponding to those found in other organisms (e.g., the S125L and S209L mutations in human mt-MTF) to assess functional conservation .

• In vitro activity assays: Characterize purified mutant enzymes using formylation assays to determine kinetic parameters (Km, Vmax, kcat) for both Met-tRNA^fMet and formyl donors. Compare these values with wild-type enzyme to quantify the impact of mutations .

• Complementation assays: Test the ability of mutant P. propionicus Fmt variants to complement E. coli Fmt deficiency, providing a functional assessment in a cellular context .

How does antifolate treatment affect Fmt activity and what are the implications for bacterial physiology?

Antifolate drugs like trimethoprim (TMP) inhibit dihydrofolate reductase (DHFR), leading to depletion of reduced folate species and accumulation of oxidized folates. Research has demonstrated several important effects on Fmt activity and bacterial physiology:

• Altered folate pools: Antifolate treatment of E. coli causes a decrease in reduced folate species (THF, 5,10-CH2-THF, 5-CH3-THF, 5,10-CH+-THF and 5-CHO-THF) and an increase in oxidized folate species (folic acid and DHF) .

• Differential sensitivity: FolD-deficient mutants and Fmt-overexpressing strains show increased sensitivity to TMP compared to Δfmt strains, suggesting that the combined effect of reduced folate pools and continued Fmt activity leads to greater growth inhibition .

• Fmt as a conduit for antifolate effects: The continued activity of Fmt under antifolate stress may contribute to the "domino effect" of TMP, where inhibition of DHFR leads to depletion of folate pools, impairment of Fmt activity, and ultimately inhibition of protein synthesis .

• Alternative substrate utilization: Under antifolate stress, accumulated 10-CHO-DHF may serve as an alternative substrate for Fmt, potentially allowing some level of translation initiation to continue. This represents an adaptive response to folate stress .

• Phase-dependent folate metabolism: 10-CHO-DHF and 10-CHO-folic acid were found to be enriched in the stationary phase, suggesting phase-dependent changes in folate metabolism that may influence Fmt activity .

What is the relationship between Fmt and other enzymes in the folate pathway?

Fmt functions within a complex network of folate-dependent enzymes and metabolic pathways:

• FolD connection: The bifunctional enzyme FolD (methylenetetrahydrofolate dehydrogenase-cyclohydrolase) produces 10-CHO-THF, the primary formyl donor for Fmt. The activity of FolD thus directly impacts Fmt function by controlling the availability of its substrate .

• Competition for 10-CHO-THF: Fmt competes with several other enzymes for 10-CHO-THF, including:

  • PurN (glycinamide ribonucleotide transformylase)

  • PurH (AICAR transformylase)

  • ArnA (UDP-4-amino-4-deoxy-l-arabinose formyltransferase)

  • PurU (formyltetrahydrofolate deformylase)

• DHFR dependency: The regeneration of THF from DHF by dihydrofolate reductase (DHFR) is essential for maintaining the pool of reduced folates available for one-carbon metabolism, including Fmt activity. Inhibition of DHFR by antifolates like TMP indirectly affects Fmt activity by limiting the availability of 10-CHO-THF .

• Feedback mechanisms: The discovery that Fmt can utilize 10-CHO-DHF suggests a potential feedback mechanism where, under conditions of DHFR inhibition, accumulated DHF derivatives can be utilized by Fmt, allowing for continued protein synthesis initiation at a reduced rate .

How can P. propionicus Fmt be used as a model system for studying formyltransferase inhibitors?

P. propionicus Fmt offers several advantages as a model system for studying formyltransferase inhibitors:

• Phylogenetic diversity: P. propionicus represents a different bacterial lineage than the commonly studied E. coli, potentially providing insights into conservation and divergence of formyltransferase mechanisms across bacterial taxa.

• Experimental tractability: The ability to express and purify recombinant Fmt enables high-throughput screening of potential inhibitors using in vitro assays .

• Comparative inhibition studies: Testing inhibitors against Fmt enzymes from multiple species, including P. propionicus, E. coli, and human mt-MTF, can help identify species-specific inhibitors with potential antimicrobial applications .

• Structure-based drug design: Although the crystal structure of P. propionicus Fmt has not been reported, homology modeling based on structures of related formyltransferases could guide rational design of inhibitors.

• Dual substrate targeting: The discovery that Fmt can utilize both 10-CHO-THF and 10-CHO-DHF opens new possibilities for designing inhibitors that target multiple aspects of Fmt function .

What techniques can be used to study Fmt activity in complex biological samples?

Several advanced techniques can be employed to study Fmt activity in complex biological samples:

• Metabolic labeling with stable isotopes: Using isotopically labeled methionine and monitoring its incorporation into N-formylmethionine-containing peptides by mass spectrometry can provide insights into Fmt activity in vivo.

• Targeted proteomics: Developing selective reaction monitoring (SRM) or parallel reaction monitoring (PRM) methods to quantify N-terminal formylmethionine in proteins can assess Fmt activity across different conditions.

• Folate metabolite profiling: Comprehensive analysis of folate metabolites by LC-MS/MS can reveal correlations between folate pool composition and Fmt activity in various physiological states .

• Ribosome profiling: This technique can provide genome-wide information on translation initiation efficiency, indirectly reflecting Fmt activity and its impact on protein synthesis .

• CRISPR interference: CRISPRi can be used to create conditional knockdowns of Fmt or related enzymes (FolD, DHFR) to study their interdependencies and functional relationships in living cells.

What are the current challenges in studying the role of Fmt in bacterial stress responses?

Several significant challenges exist in studying Fmt's role in bacterial stress responses:

• Redundancy and compensation: Bacteria may have compensatory mechanisms that activate under Fmt deficiency, making it challenging to isolate the specific contribution of Fmt to stress responses.

• Metabolic network complexity: Fmt operates within a complex network of one-carbon metabolism and protein synthesis, making it difficult to distinguish direct from indirect effects of Fmt perturbation.

• Dynamic folate pools: The composition of folate pools changes dynamically in response to environmental conditions and growth phase, requiring sophisticated analytical methods for real-time monitoring .

• Physiological relevance of alternative substrates: While 10-CHO-DHF has been shown to serve as an alternative substrate for Fmt in vitro, determining its physiological significance under various stress conditions remains challenging .

• Species-specific adaptations: The functional importance of Fmt may vary across bacterial species, particularly between obligate and facultative anaerobes like P. propionicus, requiring species-specific investigation rather than generalization from model organisms.

What are emerging areas of research regarding bacterial formyltransferases?

Emerging research areas include:

• Systems biology approaches: Integrating transcriptomic, proteomic, and metabolomic data to understand Fmt function in the context of global cellular networks.

• Structural biology: Determining high-resolution structures of Fmt enzymes from diverse bacterial species, including P. propionicus, to inform structure-based drug design.

• Single-cell analysis: Developing methods to measure Fmt activity and its effects on translation at the single-cell level to understand cell-to-cell variability.

• Synthetic biology applications: Engineering Fmt variants with altered substrate specificity or regulatory properties for biotechnological applications.

• Host-microbiome interactions: Investigating how bacterial Fmt activity influences host-microbiome interactions, particularly in environments where P. propionicus may be present.

How might understanding P. propionicus Fmt contribute to antimicrobial development?

Understanding P. propionicus Fmt could contribute to antimicrobial development in several ways:

• Novel target validation: Characterizing the essentiality of Fmt across diverse bacterial species helps validate it as a potential broad-spectrum antibiotic target.

• Selective inhibition: Identifying structural and functional differences between bacterial Fmt enzymes and human mt-MTF could enable the design of selective inhibitors with reduced risk of toxicity .

• Combination therapy approaches: Understanding the relationship between Fmt and the folate pathway could inform strategies for combination therapies targeting multiple aspects of one-carbon metabolism .

• Resistance mechanisms: Studying how bacteria adapt to Fmt inhibition or deficiency could anticipate potential resistance mechanisms and inform strategies to overcome them.

• Ecological considerations: Understanding the role of Fmt in environmental bacteria like P. propionicus could help predict ecological consequences of antimicrobial use targeting this pathway.